tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

CVS Group Cancels Further Shares as Buyback Programme Passes 1 Million Mark

Story Highlights
  • CVS Group bought 15,144 shares on 2 January 2026 for cancellation under its ongoing buyback programme.
  • Following cumulative repurchases exceeding 1 million shares, CVS now has 70.7 million shares in issue and none in treasury, consolidating voting rights for investors.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
CVS Group Cancels Further Shares as Buyback Programme Passes 1 Million Mark

Claim 50% Off TipRanks Premium

CVS Group plc ( (GB:CVSG) ) has provided an update.

CVS Group plc has continued its existing share buyback programme by purchasing 15,144 ordinary shares on 2 January 2026 at a volume-weighted average price of 1,283.48 pence per share from Berenberg. The company intends to cancel all the shares bought back, reducing the number of shares in issue to 70,691,575 and leaving no shares held in treasury; in total, since launching the programme in October 2025, CVS has repurchased 1,049,208 shares, a move that consolidates voting rights and is likely to enhance earnings per share for remaining investors.

The most recent analyst rating on (GB:CVSG) stock is a Hold with a £1320.00 price target. To see the full list of analyst forecasts on CVS Group plc stock, see the GB:CVSG Stock Forecast page.

Spark’s Take on GB:CVSG Stock

According to Spark, TipRanks’ AI Analyst, GB:CVSG is a Neutral.

CVS Group plc’s overall stock score is driven by strong financial performance and positive earnings call highlights, including revenue growth and successful acquisitions. However, the high P/E ratio and low dividend yield suggest overvaluation, while technical indicators point to potential overbought conditions. Challenges in the UK market and past cyber incidents also weigh on the score.

To see Spark’s full report on GB:CVSG stock, click here.

More about CVS Group plc

CVS Group plc is an AIM-listed provider of veterinary services operating in the UK and Australia. The group runs around 470 veterinary practices, including specialist referral hospitals and out-of-hours sites, and also operates diagnostic laboratories and the Animed Direct online retail business. CVS employs about 8,900 staff, including roughly 2,400 veterinary surgeons and 3,300 nurses, and focuses on delivering high-quality clinical services for clients and their animals.

Average Trading Volume: 433,706

Technical Sentiment Signal: Buy

Current Market Cap: £900.8M

For detailed information about CVSG stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1